Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species

Experimental Eye Research
S Y YousufzaiA A Abdel-Latif

Abstract

Prostaglandin F2 alpha (PGF 2 alpha) and its analog latanoprost are effective in lowering intraocular pressure (IOP) in both animal and human subjects. There is mounting experimental evidence now which indicates that the IOP-lowering effect of these PGs occurs through an increased uveoscleral outflow of aqueous humor. The ciliary muscle constitutes the main resistance in this pathway. Work from several laboratories, including our own, has shown that in this smooth muscle PGF 2 alpha has little effect on cAMP accumulation or on Ca2+ mobilization. In the present study, we hypothesized that some of the effects of PGF2 alpha and its analogs may be mediated through the release of endogenous PGs. The purpose of this work was to determine whether or not PGF2 alpha and its analogs can enhance the release of endogenous PGs in iris and ciliary muscles isolated from different species. This report documents for the first time that exogenous PGF2 alpha and its analogs, PhXA85 and latanoprost, stimulate the formation of PGE2, PGD2 and PGF2 alpha in iris and ciliary muscles isolated from cat, bovine, rabbit, dog, rhesus monkey and human. PG-induced PG release was demonstrated by means of both radioimmunoassay and radiochromatography. Kinetic ...Continue Reading

Citations

Jan 5, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Y TamakiA Tomidokoro
Sep 12, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·N A SharifJ Y Crider
Nov 7, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kerstin BerghJohan Stjernschantz
Jun 28, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Habib R AnsariAta A Abdel-Latif
Oct 30, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Naj A SharifAta A Abdel-Latif
Aug 27, 1999·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·T L Davis, N A Sharif
Mar 22, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Najam A SharifAta A Abdel-Latif
Mar 7, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Fatih UlaşSerdal Çelebi
Nov 25, 2006·The British Journal of Ophthalmology·Takashi OtaMakoto Araie
Jan 3, 2001·The British Journal of Ophthalmology·S SaccàG Calabria
Feb 25, 2003·The British Journal of Ophthalmology·K Kashiwagi, S Tsukahara
Jan 7, 2005·Biological & Pharmaceutical Bulletin·Masahiro OrihashiIkuko Kimura
Oct 20, 2000·American Journal of Veterinary Research·M E StuderJ Stiles
Jan 5, 2002·American Journal of Veterinary Research·A M WillisL M Schmall
Jul 30, 2014·Gastroenterology Report·Sonali PaulJames M Richter
Jan 1, 2011·Case Reports in Ophthalmological Medicine·Patrick Chiam
Feb 28, 2007·Veterinary Ophthalmology·Raymond J MorrealeMichelle A Willis
Aug 31, 2006·Cardiovascular Drug Reviews·Naruhiro IshidaHideaki Hara
Apr 14, 2016·Ophthalmic Genetics·Lance P Doucette, Michael A Walter
Dec 20, 2012·Current Eye Research·Ghalib A AkinlabiVincent Iyawe
Feb 22, 2012·Expert Opinion on Pharmacotherapy·Maurizio DigiuniLuca Rossetti
Oct 1, 2011·Seminars in Ophthalmology·Michael B Horsley, Teresa C Chen
Jun 26, 2015·American Journal of Veterinary Research·Kyle L TofflemireR David Whitley
Feb 7, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Fırat SelenÖzge Yanık
Apr 28, 2004·The Veterinary Clinics of North America. Small Animal Practice·Elizabeth A Giuliano
Nov 5, 2008·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Ho Yeop YeomGong Je Seong
Mar 11, 1998·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·G L ZhanS E Ohia
Feb 1, 2002·Journal of Glaucoma·Kenji KashiwagiShigeo Tsukahara
Nov 26, 2011·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Ece Turan-VuralSuphi Acar
May 18, 2006·Acta Ophthalmologica Scandinavica·Mandagere R Vishwanath, Stephen J Charles
Sep 28, 2007·Chinese Journal of Integrative Medicine·Guo-hong SongJun Liu
Jul 13, 2005·Veterinary Ophthalmology·Joshua T BartoeAlan H Brightman
Sep 22, 2001·Journal of Cataract and Refractive Surgery·M WandM B Shields
Aug 4, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Burkhard HinzKay Brune
Dec 14, 2016·Case Reports in Ophthalmological Medicine·Swapnil ParchandRenuka Srinivasan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Ophthalmology
William J Faulkner, Scott E Burk
Journal of Cataract and Refractive Surgery
S C SaccáM Rolando
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
T TaniguchiY Kitazawa
© 2021 Meta ULC. All rights reserved